For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Research and development | 27,265 | 27,387* | 22,474 | 21,170 |
| In-process research and development | 150,000 | -4,750* | 2,000 | 7,500 |
| General and administrative | 10,646 | 9,261* | 10,072 | 9,455 |
| Total operating expenses | 187,911 | 31,897 | 34,546 | 38,125 |
| Loss from operations | -187,911 | -31,897* | -34,546 | -38,125 |
| Other expense, net | - | 5* | - | 81 |
| Interest income | 4,449 | 4,090* | 3,971 | 4,330 |
| Other income (expense), net | 22 | - | -37 | - |
| Total other income (expense), net | 4,471 | 4,085* | 3,934 | 4,249 |
| Net loss | -183,440 | -27,813* | -30,612 | -33,876 |
| Unrealized (loss) gain on marketable securities, net | -1,327 | 192* | 234 | -213 |
| Comprehensive loss | -184,767 | -27,622 | -30,378 | -34,089 |
| Basic EPS | -0.6 | -0.097 | -0.11 | -0.12 |
| Diluted EPS | -0.6 | -0.097 | -0.11 | -0.12 |
| Basic Average Shares | 304,317,460 | 283,563,788 | 283,681,570 | 283,355,730 |
| Diluted Average Shares | 304,317,460 | 283,563,788 | 283,681,570 | 283,355,730 |
Erasca, Inc. (ERAS)
Erasca, Inc. (ERAS)